Recent nanotechnology advancements to treat multidrug-resistance pancreatic cancer: Pre-clinical and clinical overview

Pancreatic cancer (PC) remains one of the most lethal and incurable forms of cancer and has a poor prognosis. One of the significant therapeutic challenges in PC is multidrug resistance (MDR), a phenomenon in which cancer cells develop resistance toward administered therapy. Development of novel the...

Descripción completa

Detalles Bibliográficos
Autores principales: Alshememry, Abdullah K., Alsaleh, Nasser B., Alkhudair, Nora, Alzhrani, Rami, Alshamsan, Aws
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449524/
https://www.ncbi.nlm.nih.gov/pubmed/36091785
http://dx.doi.org/10.3389/fphar.2022.933457

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449524/
https://www.ncbi.nlm.nih.gov/pubmed/36091785
http://dx.doi.org/10.3389/fphar.2022.933457

Ejemplares similares